|
BHB-1893 Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 3: 1
Top Sponsors
- Braveheart Bio, Inc.1
Indications
- Cardiomyopathy, Hypertrophic Obstructive1
- Heart Disease1
Manhasset, New York1 trial
BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy
LIONHEART-HCM Site 0107
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.